Navigation Links
Aptima in Medical News

Gen-Probe Reports Financial Results for Second Quarter 2009

...plant diagnostics and genetic testing products, and continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously d... information, go to www.gen-probe.com. Trademarks APTIMA, aptima COMBO 2, PACE, PROGENSA and TIGRIS are trademarks of Gen-Probe Incorporated...

Gen-Probe Reports Financial Results for First Quarter 2009

...ter of 2009 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...ngoing European market development efforts for the aptima Combo 2, aptima HPV and PROGENSA(TM) PCA3 assays. General a...

Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement

...t and general counsel. "We continue to expect our aptima HPV assay, which is available in Europe and is in ...oncerning future development, the potential of the aptima HPV assay, and reimbursement of legal expenses are...e may not successfully complete development of our aptima HPV assay, (ii) the risk that the HPV market will ...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008

...rter of 2008 reflected the continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...IO assay in the United States, the investigational aptima human papillomavirus (HPV) assay, and Gen-Probe's ...arket development efforts related to the Company's aptima Combo 2,...

Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance

...ter of 2008 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...IO assay in the United States, the investigational aptima human papillomavirus (HPV) assay, and Gen-Probe's ...arket development efforts related to the Company's aptima Combo 2,...
Aptima in Medical Technology

Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer

...ly result in the introduction of a highly accurate aptima HPV assay that improves the detection and treatment of cervical cancer." The investigational aptima HPV assay is an amplified nucleic acid test that d...re normal. This arm will assess the ability of the aptima HPV test to identify women who are at greater risk...
Aptima in Medical Products

Aptima Combo 2® Assay

Description:... The aptima COMBO 2 Assay is a second generation nucleic acid amplification test that uses target capture for in vitro qualitative detection and differentiation o...
Company:Gen-Probe
Aptima in Biological Technology

Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting

...sia (EUROGIN) in Nice, France. Gen-Probe's aptima HPV assay has been CE-marked for sale in the Europ... "As a whole, these studies suggest that our new aptima HPV assay may detect high-risk HPV infections that... director, presented interim results of the French aptima HPV Screening Evaluation (FASE) study from 1,528 w...

Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus

...lomavirus (HPV), which causes cervical cancer. The aptima HPV Assay has been CE marked and is currently avai...ion countries. "The CE marking and launch of our aptima HPV Assay in Europe reflect Gen-Probe's commitment... and future automated instrument platforms." The aptima HPV Assay is an amplified nucleic acid test that d...

Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance

...ter of 2008 benefited from continued growth of the aptima Combo 2(R) assay, an amplified nucleic acid test (...ent resulted primarily from increased sales of the aptima Combo 2 assay and from commercial pricing of the P...arket development efforts related to the Company's aptima HPV and PROGENSATM PCA3 assays. General and admi...

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007

...n the fourth quarter of 2007 were again led by the aptima Combo 2(R) assay, an amplified nucleic acid test (...t efforts related to the Company's investigational aptima HPV assay. For the full year 2007, marketing and s...e led by continued market share gains for the aptima Combo 2 assay, by commercial pricing of the P...

Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues

...in the third quarter of 2007 were again led by the aptima Combo 2(R) assay, an amplified nucleic acid test (...o http://www.gen-probe.com . Trademarks APTIMA, aptima COMBO 2, PACE and TIGRIS are trademarks of Gen-Pro...le of our new products, such as our TIGRIS system, aptima Combo 2 assay, PROCLEIX ULTRIO assay and PROGENSA ...
Other Tags
(Date:8/29/2015)... ... August 29, 2015 , ... ... two inventors from Miller Place, N.Y. "I specialize in manual therapy, and my ... addition, it can be used for additional muscle dysfunction throughout the body." , ...
(Date:8/29/2015)... ... 2015 , ... Dr. Tim Novelli, DC., Founder and President of the Patriot ... of the chiropractic field in the military. All too often VA hospitals treat patients ... made available to the VA program over a decade ago, the reality is that ...
(Date:8/29/2015)... ... , ... ProDrop Particles includes over 40 particle backdrops designed for use in ... that users can shrink and stretch in the Final Cut Pro X timeline. Choose ... brightness, scale, speed, range, and flare attributes with intuitive controls found in the top-right ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES IN ... announced that it will be devoting an entire short segment to the subject of ... around the globe on a daily basis, but recent advancements in medical science may ...
(Date:8/28/2015)... ... August 28, 2015 , ... Joining a ... Memorial Hospital recently transitioned management companies to partner with Wound Care Advantage (WCA) ... outpatient wound center. , Transitioning wound care management providers can be a ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/5/2015)... , August 5, 2015 ... titled "Facial Recognition Market - Global Industry Analysis, Size, ... global market for facial recognition is forecast to reach ... by increased demand for surveillance systems by civil and ... number of crimes and terrorist activities across the globe ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
Other Contents